A Proposed New Role for the Insurance Industry in Biomedical Research Funding

Publisher Website
Google Scholar
Abstract
DESPITE the explosion in biotechnology, over the past 10 to 15 years there has been a gradual decline in the support of biomedical research in the United States. This is true whether support is considered in terms of constant dollars or the fraction of total health-care costs devoted to research. Thus, in 1970 about 3.9 per cent of all health-care dollars were devoted to research and development, whereas by 1982 the figure had declined to only 2.9 per cent, or $9.2 billion for research and development, as compared with a total health-care budget of $317 billion.1 By any industrial standard, . . .

This publication has 0 references indexed in Scilit: